-
WES data from primary CRCs tissues in ctDNA positive patients
Study
EGAS50000000650
-
WES data from primary CRC
Dataset
EGAD50000000924
-
SMPaeds PanelSeq of cfDNA at relapse with UMIs
Dataset
EGAD50000000781
-
SMPaeds PanelSeq of tumour tissue
Dataset
EGAD50000000783
-
Transplant Outcomes in Aplastic Anemia (TOAA): GWAS and Whole Exome Sequence Data
Study
phs001710
-
Single-cell RNA sequencing of human skin tumors (BCC, SCC and Melanoma)
Study
EGAS50000000365
-
Base-excision repair pathway shapes 5-methylcytosine deamination signatures in pan-cancer genomes
Study
EGAS50000000536
-
Neoadjuvant nivolumab or nivolumab plus ipilimumab in early-stage triple negative breast cancer: phase 2 adaptive BELLINI trial. WES
Study
EGAS50000000568
-
Whole-genome sequencing of BRCA-mutant breast cancer patient samples from tumour, germline tissue and plasma
Study
EGAS50000000569
-
Neoadjuvant nivolumab or nivolumab plus ipilimumab in early-stage triple negative breast cancer: phase 2 adaptive BELLINI trial. RNA-Seq
Study
EGAS50000000567